2nd Nov 2015 15:07
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIESREPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | FMR LLC and/or one or more of its direct or indirect subsidiaries And FIL Limited and/or one or more of its direct and indirect subsidiaries
|
Company dealt in | ALLERGAN PLC |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | Ordinary Shares and preferred convertible stock |
| Date of dealing | 30-October-15 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant securitydealt in (Note 3)
Ordinary Shares | Long | Short |
| Number (%) | Number (%) |
(1) Relevant securities
| 16,616,876 4.21% |
|
(2) Derivatives (other than options)
|
|
|
(3) Options and agreements to purchase/sell
|
|
|
Total
| 16,616,876 4.21% |
|
Please note that the above positions include a transfer out for 9,549 shares.
Preferred Convertible Stock | Long | Short |
| Number (%) | Number (%) |
(1) Relevant securities
| 249,120 4.92% |
|
(2) Derivatives (other than options)
|
|
|
(3) Options and agreements to purchase/sell
|
|
|
Total
| 249,120 4.92% |
|
(b) Interests and short positions in relevant securities of the company, other than theclass dealt in (Note 3)
Class of relevant security:
| Long | Short |
| Number (%) | Number (%) |
(1) Relevant securities
| ||
(2) Derivatives (other than options)
| ||
(3) Options and agreements to purchase/sell | ||
Total
|
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale
| Number of securities | Price per unit |
Sale | 2,568 | 311.8135 USD/ Share |
Sale | 1,300 | 311.7454 USD/ Share |
Sale | 7,800 | 312.7586 USD/ Share |
Sale | 6,800 | 310.2222 USD/ Share |
Sale | 13,617 | 310.3739 USD/ Share |
Sale | 30,900 | 315.0255 USD/ Share |
Sale | 6,785 | 317.0008 USD/ Share |
Sale | 7,399 | 315.0049 USD/ Share |
Sale | 300 | 312.188 USD/ Share |
Buy (preferred convertible stock 2.8345 conversion factor) | 5,900 | 1,051.3425 USD/ Share |
Buy (preferred convertible stock 2.8345 conversion factor) | 2,610 | 1,048.05 USD/ Share |
Sale | 100 | 312.39 USD/ Share |
Sale | 300 | 311.6233 USD/ Share |
Sale | 400 | 312.2 USD/ Share |
Sale | 10,160 | 313.3172 USD/ Share |
Sale | 7,400 | 312.36 USD/ Share |
Sale | 2,100 | 313.5838 USD/ Share |
Sale | 12,200 | 314.093 USD/ Share |
Sale | 71,300 | 314.9174 USD/ Share |
Sale | 10,200 | 313.5054 USD/ Share |
Sale | 9,918 | 311.0793 USD/ Share |
Sale | 3,757 | 311.0575 USD/ Share |
Sale | 3,400 | 310.7115 USD/ Share |
Sale | 1,000 | 311.02 USD/ Share |
Sale | 1,600 | 310.6913 USD/ Share |
Sale | 200 | 311.665 USD/ Share |
Sale | 215 | 308.24 USD/ Share |
Sale | 1,300 | 313.8569 USD/ Share |
Sale | 100 | 314.15 USD/ Share |
Sale | 2,100 | 315.355 USD/ Share |
Sale | 65 | 312.7 USD/ Share |
Sale | 4,700 | 311.3294 USD/ Share |
Sale | 8,200 | 308.47 USD/ Share |
Sale | 400 | 311.985 USD/ Share |
Sale | 432 | 311.5895 USD/ Share |
Buy | 500 | 312.252 USD/ Share |
Buy | 400 | 312.2 USD/ Share |
Buy | 1,000 | 311.02 USD/ Share |
Buy | 36 | 307.24 USD/ Share |
Buy | 14 | 310.655 USD/ Share |
Buy | 187 | 311.47 USD/ Share |
Buy | 21 | 310.65 USD/ Share |
Buy | 10 | 251.9708 USD/ Share |
Buy | 7 | 304.76 USD/ Share |
Buy | 2 | 310.66 USD/ Share |
Buy | 2 | 307.245 USD/ Share |
Sale | 8 | 310.044 USD/ Share |
Sale | 20 | 310.70 USD/ Share |
Sale | 26 | 310.04 USD/ Share |
Sale | 6 | 275.53 USD/ Share |
Sale | 8 | 310.71 USD/ Share |
Sale | 1 | 309.72 USD/ Share |
Sale | 7 | 310.02 USD/ Share |
Sale | 2 | 310.76 USD/ Share |
Sale | 403 | 308.47 USD/ Share |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of securities (Note 7) | Price per unit (Note 5) |
|
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option
| Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5)
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8)
| Details | Price per unit (if applicable) (Note 5) |
|
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
|
Is a Supplemental Form 8 attached? (Note 9) No
| Date of disclosure | 02-November-15 |
| Contact name | Sally-Ann Hatton |
| Telephone number | 01737 837148 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
| If a connected EFM, state nature of connection (Note 10) | N/A |
Related Shares:
PFZ.L